1800 202 8726
Premalignant conditions

Barrett's Oesophagus and Dysplasia: — What Your Biopsy Result Means

A Barrett's diagnosis does not resolve anything cleanly. The lining of your food pipe has changed, the risk of cancer is real but small, and the answer is lifelong surveillance rather than treatment. Understanding the grade in your biopsy result is where your plan begins.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Not cancer — Barrett's oesophagus is a premalignant change. But it does not go away, and it needs lifelong monitoring.
  • The grade drives the plan — Dysplasia — absent, low-grade or high-grade — determines how often you need a gastroscopy.
  • Low absolute risk, long commitment — Annual progression rates are small. The monitoring programme lasts your lifetime. Both are true at once.
  • Surveillance, not treatment, for most — Most people with Barrett's are monitored with regular gastroscopy rather than treated straight away.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Barrett's oesophagus is a change in the cells lining the lower food pipe, caused by long-term acid reflux. A biopsy grades any further change — called dysplasia — as absent, low-grade or high-grade. That grade determines your surveillance interval. It is not cancer, but it is a reason for lifelong monitoring.

What is Barrett's oesophagus, and is it cancer?

Barrett's oesophagus is not cancer. It is a premalignant condition — meaning the cells lining the lower food pipe have changed into a type more like intestinal lining, driven by years of acid reflux damaging the tissue.

Because these changed cells carry a higher risk of developing into oesophageal adenocarcinoma than normal cells do, they need to be watched. That is the purpose of the surveillance programme: to catch any further change at the earliest possible point.

The biopsy taken during your gastroscopy tells you whether there is any additional change within the Barrett's lining. That change is called dysplasia, and it is graded as absent, low-grade, or high-grade. Each grade means a different surveillance interval.

What is the risk that Barrett's will become cancer?

The risk is real but small in absolute terms. The British Society of Gastroenterology estimates the annual rate of progression from Barrett's without dysplasia to oesophageal adenocarcinoma as less than 0.3% per year. Most people with Barrett's do not develop oesophageal cancer in their lifetime.

When low-grade dysplasia is present, the risk is higher — but estimates in the published literature vary considerably. A single biopsy reading of low-grade dysplasia is often reviewed by a second pathologist before management decisions are made, because the diagnosis is not always straightforward.

High-grade dysplasia carries a meaningfully higher risk and is generally treated rather than surveilled. Endoscopic procedures — carried out through the gastroscope — can remove the affected segment without open surgery.

What your own result means depends on the extent of your Barrett's segment, the grade, and other individual factors. That is a conversation for your gastroenterologist, not a risk table.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What do you need to keep track of after a Barrett's diagnosis?

  • Know your next endoscopy date — and protect it. Missing a surveillance scope is the main way the programme fails.
  • Tell your team about any new symptoms between scopes: difficulty swallowing, food getting stuck, or chest pain that is new or worsening.
  • Take your acid-suppressing medicine as prescribed, even when you have no symptoms. Reflux continues to act on the Barrett's lining silently.
  • Tell your team about everything you are taking, including herbal preparations and supplements, as some interact with prescribed medicines.
  • If you smoke, tell your team. Smoking is relevant to your risk and to how your medicines work.
  • Ask for written confirmation of your dysplasia grade and your surveillance interval at each appointment. Write it down before you leave.

Did you know?

Surveillance endoscopy does not prevent Barrett's from progressing — it finds any change early, when endoscopic treatment is most likely to work.

The most important question to leave your appointment with is not your risk percentage. It is your next scope date.

Source: British Society of Gastroenterology Barrett's Oesophagus Guidelines

Explore 102 more Your Result, What Comes Next and Support topics

HUB — Who Can Have a Biopsy? Special Situations

HUB — Your Biopsy Confirmed Cancer

All Your Result, What Comes Next and Support →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Will Barrett's oesophagus ever go away on its own?

Rarely. Regression happens in a small number of people — particularly with tight acid control — but in most cases Barrett's persists. The goal of acid-suppressing medicine is to reduce further damage to the lining, not to reverse the change already there. Do not stop the medicine without speaking to your team, because reflux continues to act on the affected segment even when it causes no noticeable symptoms.

What does low-grade dysplasia on my biopsy mean?

It means the cells in your Barrett's segment show early abnormal changes, one step beyond Barrett's without dysplasia. The progression risk is higher than with no dysplasia, but estimates in the literature vary considerably, and the diagnosis is not always straightforward on a single biopsy. ESGE and BSG guidelines recommend that confirmed low-grade dysplasia be reviewed by a second pathologist before management decisions are made. Ask your team whether your result has been confirmed by two pathologists and what the next step is for you specifically.

How often will I need a gastroscopy?

Surveillance intervals depend on the grade of dysplasia and the length of your Barrett's segment. In Barrett's without dysplasia, BSG and ESGE guidelines recommend intervals measured in years, with the exact interval depending on segment length. For confirmed low-grade dysplasia, the interval is shorter and specialist review may be recommended. High-grade dysplasia is generally treated rather than surveilled. Ask for your specific interval in writing before you leave the appointment — that number matters more than any other you will hear that day.

What happens if high-grade dysplasia is found?

High-grade dysplasia is not cancer, but ESGE and BSG guidelines recommend treatment rather than continued surveillance in most cases. Endoscopic therapies — including radiofrequency ablation and endoscopic mucosal resection — can remove the affected area through the gastroscope, without open surgery. These procedures are carried out at specialist centres. If you have been told you have high-grade dysplasia and have not yet been referred to a specialist centre, ask for that referral.

Can I do anything to reduce the risk?

The evidence for lifestyle changes in Barrett's is less definitive than for some other cancers, but your team will generally recommend tight acid control with prescribed medicine, maintaining a healthy weight, stopping smoking if you smoke, and not lying down immediately after meals. These are worth doing. None of them removes the need for the surveillance programme, and none replaces it. If you use any herbal or traditional preparations for reflux, tell your treating team — some interact with acid-suppressing medicine.

My biopsy says no dysplasia — does that mean I am safe?

It is the best possible result from a surveillance scope, and it means there is no abnormal cellular change in the Barrett's segment right now. It does not mean you are discharged from surveillance. Barrett's without dysplasia still carries a small but real long-term risk, and the surveillance programme continues precisely because that risk does not disappear with a normal result. A no-dysplasia result is reassuring — and it is also the reason your next scope is still scheduled.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation